1. Home
  2. SABS vs GFAI Comparison

SABS vs GFAI Comparison

Compare SABS & GFAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SABS
    SELLHOLDBUYas of 3 days ago
  • GFAI
    SELLHOLDBUYas of 3 days ago
  • Stock Information
  • Founded
  • SABS 2014
  • GFAI 2018
  • Country
  • SABS United States
  • GFAI Singapore
  • Employees
  • SABS N/A
  • GFAI N/A
  • Industry
  • SABS Biotechnology: Pharmaceutical Preparations
  • GFAI Diversified Commercial Services
  • Sector
  • SABS Health Care
  • GFAI Consumer Discretionary
  • Exchange
  • SABS Nasdaq
  • GFAI Nasdaq
  • Market Cap
  • SABS 19.0M
  • GFAI 20.7M
  • IPO Year
  • SABS N/A
  • GFAI N/A
  • Fundamental
  • Price
  • SABS $1.13
  • GFAI $0.90
  • Analyst Decision
  • SABS Strong Buy
  • GFAI Strong Buy
  • Analyst Count
  • SABS 5
  • GFAI 2
  • Target Price
  • SABS $11.40
  • GFAI $6.75
  • AVG Volume (30 Days)
  • SABS 40.5K
  • GFAI 356.3K
  • Earning Date
  • SABS 05-19-2025
  • GFAI 04-28-2025
  • Dividend Yield
  • SABS N/A
  • GFAI N/A
  • EPS Growth
  • SABS N/A
  • GFAI N/A
  • EPS
  • SABS N/A
  • GFAI N/A
  • Revenue
  • SABS $1,322,410.00
  • GFAI $35,841,743.00
  • Revenue This Year
  • SABS N/A
  • GFAI $0.37
  • Revenue Next Year
  • SABS $25.00
  • GFAI $5.60
  • P/E Ratio
  • SABS N/A
  • GFAI N/A
  • Revenue Growth
  • SABS N/A
  • GFAI 1.78
  • 52 Week Low
  • SABS $1.00
  • GFAI $0.82
  • 52 Week High
  • SABS $5.01
  • GFAI $4.09
  • Technical
  • Relative Strength Index (RSI)
  • SABS 27.84
  • GFAI 34.16
  • Support Level
  • SABS $1.11
  • GFAI $0.95
  • Resistance Level
  • SABS $1.80
  • GFAI $1.03
  • Average True Range (ATR)
  • SABS 0.15
  • GFAI 0.07
  • MACD
  • SABS -0.02
  • GFAI -0.00
  • Stochastic Oscillator
  • SABS 16.25
  • GFAI 19.40

Stock Price Comparison Chart: SABS vs GFAI

SABS
GFAI
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April020406080100120140160SABS VS GFAI

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is a provider of cash solutions and cash handling services located in Thailand. The company engages in the cash logistics business, and its services include cash-in-transit, or CIT, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions (cash deposit management and express cash service). Its customers include local commercial banks, chain retailers, coin-manufacturing mints, and government authorities.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use